openPR Logo
Press release

Data Analytics To Usurp The Electrophysiology Ablation Market, Reaching US$ 6.3 Bn

Data Analytics To Usurp The Electrophysiology Ablation Market,

The global Electrophysiology Ablation Market is estimated to grow at the rate of 8.4% in the upcoming period, reaching US$ 6.3 Bn by the year 2031. Integration with virtual reality solutions is expected to rule the roost in the forecast period. Augmented reality could be used for accessing information as well as reports while handling patients or without having to leave their existing operations, that too, in a completely hands-free mode, through voice command, or making supportive data appear automatically. This would be the healthcare vertical in future.

According to a recent study by Persistence Market Research, the global electrophysiology ablation market is expected to witness high growth from US$ 2.5 Bn in 2021 to US$ 6.3 Bn by 2031. This reflects a CAGR of around 8.4% over the forecast period (2021-2031).

Rising morbidity and mortality due to cardiac disorders, especially arrhythmia, make this market more demanding. Moreover, new product innovation and increased adoption of electrophysiology ablation devices by cardiologists in hospitals is expected to boost market growth over the forecast period.

The market is experiencing drastic changes with high adoption of electrophysiology ablation procedures due to rising awareness about cardiac health. Sales and marketing practices by some manufacturers are influencing the procedure and device cost in selective regions. Additionally, rising investments in the healthcare sector in emerging regions and reimbursement policies for cardiac ablation are further expected to give positive growth to this market.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25474

Technological innovations are warranted to improve the safety and effectiveness of ablation devices, thereby helping market growth. Significant growth has been observed in two of the most dynamic segments: cardiac rhythm management (CRM) and electrophysiology (EP) segment, in recent years.

From the last few years, there has been considerable progress and innovation made in developing advances in heart rhythm therapy. Ongoing researches in this segment will help create the landscape for further product advancement in the electrophysiological ablation market. As the market is consolidated in terms of catheters being used, market leaders are focusing on increasing their product portfolios to strengthen their product acceptability at the end user level globally.

For instance, in June 2021, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for the Arctic Front™ set of cardiac cryoablation catheters.

Leading players are focusing on investment in developing countries to increase their foothold in the market. Also, major market players have been concentrating on enhancing gains through advancements in distribution channels.

Company Profiles:

Biomerics
Biosense Webster
Abbott Laboratories
MEDTRONIC PLC
Boston Scientific Corporation
CathRx Ltd
Japan Lifeline Co
ATRICURE, INC.
Auris Health

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25474

Key Takeaways from Market Study

With advanced product features and more acceptance by end users, ablation catheters hold a high market share around 47.4%.

52.5% market share is held by the atrial fibrillation (AF) segment of electrophysiology ablation, due to high prevalence of this disease and need for its treatment.

Hospitals are expected to enjoy more than half of the market share during the forecast period because of high adoption of electrophysiology ablation devices and procedures and increased number of walk-in patients.

North America market is expected to grow 2.5X over the forecast duration due to rising prevalence of conditions such as atrial fibrillation and tachycardia, growing awareness regarding cardiac health, and presence of reimbursement policies in the region.

"Increasing adoption of technologically advanced devices and growing awareness about cardiac disorder and associated risks are expected to drive demand for electrophysiology ablation over the decade," says a Persistence Market Research Analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25474

Who is Winning?

Major manufacturers of electrophysiology ablation devices have been focusing on product launches, collaborations, and partnerships for global expansion.

BIOTR's product the Force Sensing Ablation Catheter, the first and only gold-tipped to support effective ablations in the left atrium, got CE approval in 2020.

Likewise, AtriCure got into a strategic collaboration with Baheal Group for a distribution agreement to market its products across China.

Major market players covered in the report include Biosense Webster (Johnson & Johnson), Abbott Laboratories, MEDTRONIC PLC, Boston Scientific Corporation, CathRx Ltd, SE & Co. KG., Japan Lifeline Co, ATRICURE, INC., Auris Health, and Biomerics.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on electrophysiology ablation market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021-2031, based on product (diagnostic catheters, ablation catheters, and access devices), application (supraventricular tachycardia (SVT) ablation, ventricular tachycardia(VT/VPC), and atrial fibrillation (AF)), and end user (hospitals, ambulatory surgical centers, and clinics), across seven key regions of the world.

Access Related Reports-

Allergy Shots Market: https://www.persistencemarketresearch.com/market-research/allergy-shots-market.asp

Effervescent Products Market: https://www.persistencemarketresearch.com/market-research/effervescent-products-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Data Analytics To Usurp The Electrophysiology Ablation Market, Reaching US$ 6.3 Bn here

News-ID: 2625847 • Views: 239

More Releases from Persistence Market Research

Availability Of Programs Driving Measurable Outcomes To Drive The Surgical Imagi …
As per the report by Persistence Market Research (PMR), the global surgical imaging market is expected to experience moderate growth throughout the forecast period 2017-2026. The market is estimated to increase to 4.4% CAGR. By the end of 2026, the global surgical imaging market is estimated to reach US$ 1,384.5 million in revenue. Growing demand for medical surgeries based on image guides. Additionally, the increasing number of hospitals and healthcare centers
Medical Tapes And Bandages Market To Witness A Customized Procurement Strategy A …
According to the latest report by Persistence Market Research (PMR), the global medical tapes and bandages market is expected to witness sluggish growth. The market is estimated to increase to 3.6% CAGR during the forecast period 2017-2022. It is also expected to reach US$ 7,403.0 million revenue by the end of 2022. In order to fasten the process of healing the wound, and provide protection from bacteria and environmental factors such
Cardiac Arrhythmia Monitoring Devices Market To Expand Based On Agile Supply Cha …
Persistence Market Research has recently published a new report titled "Cardiac Arrhythmia Monitoring Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)" which is an extensive market study covering various aspects of cardiac arrhythmia monitoring devices that include analysis on various product types, end users and applications. The segmental analysis is done on a global scale as well as across the key regions of North America, Latin America, Europe, Asia
Remote Care Systems Through Digitization To Drive The Arthroscopic Shaver Market …
The Arthroscopic Shaver Market is destined to grow on an impertinent note, i.e. reaching US$ 600 Mn at a CAGR of 5.5% between 2017-2026. Personalization has taken over almost every sphere of the industry verticals, and healthcare is no exception. People have started looking at their healthcare picture such that they could actively take part in improving their physical and mental health on the daily basis. This personalization will be

All 5 Releases


More Releases for Ablation

01-21-2021 | Health & Medicine
Fact.MR
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems. Request
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,
Global Tumor Ablation Market Outlook To 2026
Global Tumor Ablation Market Outlook To 2026: In-Depth Market Overview, Key Treatment Type (Surgical, Percutaneous), Technology (Cryoablation, IRE, MWA, RFA), Application Categories (Liver, Lung, Breast, Prostate), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The Tumor Ablation Market was valued at $1.08Billion in 2018 and is forecast to grow at a modest12.2% CAGR between2018 and 2025, culminating in 2026 global sales of $4.2Billion. Tumor Ablation
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Endometrial Ablation Market Growth Analysis 2024
TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024. Rising Rate of Incidence of Gynecological Diseases to Drive Market The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The